QTREX Quantum Ltd. has regained compliance with Nasdaq’s minimum bid price requirement, continuing to trade under symbol "QTEX".
Quiver AI Summary
QTREX Quantum Ltd. announced that it has regained compliance with Nasdaq's minimum bid price requirement, following confirmation from Nasdaq that its ordinary shares traded at $1.00 or more for ten consecutive business days from October 2 to October 15, 2026. As a result, Nasdaq has deemed the matter closed, and the company remains listed under the symbol "QTEX." QTREX focuses on advancing Additively Manufactured Electronics for quantum computing and other high-tech applications, while also developing medical technology solutions. The company continues to evolve its business and actively explore monetization opportunities within its medical technology portfolio.
Potential Positives
- QTREX Quantum Ltd. has regained compliance with Nasdaq's minimum bid price requirement, indicating financial stability and a positive outlook for the company's stock.
- The company's ordinary shares continue to be listed and traded on The Nasdaq Capital Market under the symbol "QTEX," which is significant for maintaining investor confidence and market presence.
Potential Negatives
- The press release indicates that the company was previously not in compliance with Nasdaq's minimum bid price requirement, reflecting potential financial instability or poor market perception prior to the recent compliance announcement.
- Even after regaining compliance, the necessity for such notifications may signal ongoing challenges in maintaining investor confidence and share price stability.
- The mention of ongoing risks and uncertainties, particularly related to forward-looking statements, may raise concerns among investors about the company's future performance.
FAQ
What recent compliance confirmation did QTREX receive from Nasdaq?
QTREX confirmed it has regained compliance with Nasdaq's minimum bid price requirement for its ordinary shares.
How long was QTREX's closing bid price above $1.00?
The closing bid price was above $1.00 for 10 consecutive business days, from October 2 to October 15, 2026.
What is the trading symbol for QTREX on Nasdaq?
The trading symbol for QTREX on Nasdaq is "QTEX".
What fields does QTREX Quantum Ltd. focus on?
QTREX focuses on quantum computing, advanced connectivity, electronics manufacturing, and medical technology solutions.
Where can I find more information about QTREX?
More information about QTREX can be found on their website at www.q-trex.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$QTEX Insider Trading Activity
$QTEX insiders have traded $QTEX stock on the open market 8 times in the past 6 months. Of those trades, 4 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $QTEX stock by insiders over the last 6 months:
- DAGI SHAHAR BEN-NOON (Chief Executive Officer) has made 3 purchases buying 201,168 shares for an estimated $170,904 and 0 sales.
- YAFIT TEHILA (Chief Financial Officer) has made 0 purchases and 4 sales selling 60,000 shares for an estimated $143,961.
- TAL PARNES purchased 6,666 shares for an estimated $9,999
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$QTEX Hedge Fund Activity
We have seen 16 institutional investors add shares of $QTEX stock to their portfolio, and 5 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC removed 4,139,086 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $5,960,283
- YORKVILLE ADVISORS GLOBAL, LP removed 1,977,724 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $2,847,922
- CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD added 249,061 shares (+inf%) to their portfolio in Q2 2026, for an estimated $358,647
- FOUNDATIONS INVESTMENT ADVISORS, LLC added 198,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $285,120
- JANE STREET GROUP, LLC added 121,885 shares (+608.0%) to their portfolio in Q2 2026, for an estimated $175,514
- VIRTU FINANCIAL LLC added 106,974 shares (+inf%) to their portfolio in Q2 2026, for an estimated $154,042
- LPL FINANCIAL LLC added 43,200 shares (+inf%) to their portfolio in Q2 2026, for an estimated $62,208
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
Ness Ziona, Israel, Oct. 19, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure, announced today that on October 16, 2026 it received a written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).
Nasdaq determined that for 10 consecutive business days, from October 2, 2026 to October 15, 2026, the closing bid price of the Company’s ordinary shares was $1.00 per share or greater. Accordingly, Nasdaq informed the Company that the matter is now closed. The Company’s ordinary shares continue to be listed and traded on The Nasdaq Capital Market under the symbol “QTEX”.
About QTREX Quantum
QTREX Quantum Ltd. (Nasdaq: QTEX) is a technology company focused on advanced connectivity and electronics manufacturing solutions for quantum computing and other advanced hardware markets. Following its acquisition of the AME platform, the Company is developing high-density, thermally optimized quantum connectivity solutions for dilution cryostats and advancing AME applications for defense, aerospace, missile, space, and other mission-critical environments. The Company also continues to advance its medical technology portfolio, including respiratory support and blood monitoring platforms, while actively working to monetize certain parts of the medical business.
For more information, please visit: www.q-trex.com
Forward-Looking Statement Disclaimer
This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses its continued listing on The Nasdaq Capital Market. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements. More detailed information about the risks and uncertainties affecting the Company is contained under “Risk Factors” in the Company’s annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission.
Company Contact
QTREX Quantum
Email: [email protected]
Phone: +972-9-9664485
